Scalar Closed Loop Intraoperative Study
Scalar Closed Loop Intraoperative Study
The purpose of this study is to measure neural activity during deep brain stimulation (DBS).
 There are two types of neural activity that we will record from DBS electrodes during this
 study: DBS local evoked potentials (DLEPs) and spontaneous, local field potentials (LFPs). We
 will measure the effects of varying stimulation parameters on both the neural activity and
 changes in motor symptoms -- bradykinesia and tremor -- in subjects with Parkinson's disease
 (PD). Correlating neural activity characteristics with changes in symptoms will improve our
 understanding of the mechanisms of action of DBS. This intraoperative study will specifically
 compare our ability to record neural activity using circuitry developed at Duke for this
 purpose [Kent et al, 2015] to a new, implanted pulse generator (IPG; RC+S) developed by
 Medtronic. These intraoperative studies will specifically test a preliminary version of the
 RC+S (that is not designed for implantation), and will lead to a clinical trial assessing the
 efficacy of the implantable RC+S IPG in PD patients once this device is available and
 approved for this trial.
The investigator will measure DBS local evoked potentials (DLEPs) and/or local field
 potentials (LFPs) together with motor symptoms (tremor and/or bradykinesia) in response to
 deep brain stimulation (DBS). The study will be conducted in the operating room at Duke
 University Medical Center. Additional operating room costs will be covered by institutional
 resources at Duke. The study will be performed on subjects who are undergoing implantation of
 the DBS system during an awake, stereotactic procedure for PD.

 The subject group will only include patients undergoing a DBS implant procedure for PD. The
 surgical procedure will proceed as needed for treatment of Parkinson's disease (PD),
 including implantation of the DBS electrode (one into STN or dual electrodes into STN and
 GPi/GPe) into the targeted regions of the brain. For this research, subjects will receive
 temporary (~45 min) percutaneous extensions to the DBS electrode(s) and DBS lead cannula
 after implantation. These temporary extensions will connect to both our Duke stimulation and
 recording system or the Medtronic RC+S test recording system, alternating as needed, to allow
 recording and direct comparison of neural DLEP responses and/or LFPs using the two different
 stimulation/recording systems. Details of the stimulation and recording system are provided
 in the Study Interventions section. After the study is completed, the second DBS electrode
 (if placed) and the temporary percutaneous extensions will be removed. Then, the ordinary
 clinical conduct of the procedure will continue for treatment of the patient's movement
 disorder.

 The investigator will measure tremor and/or bradykinesia in persons with PD during DBS.
 Subjects will be familiarized with and able to practice the evaluation tasks before
 preparation for surgery. Further, they will be asked to discontinue use of dopaminergic
 and/or anti-tremor medications overnight prior to the study (as is the clinical routine), to
 reduce variability of motor symptoms due to the time course of medications. The investigator
 will conduct evaluations using unilateral stimulation, with the limb contralateral to the
 side of stimulation used for measurement of motor symptoms. Subjects may also be asked to
 rate any side effects that they experience on a 0 - 10 scale.

 Contacts on the subject's DBS electrode will be used for stimulation and recording. The four
 DBS contacts are designated as 0-1-2-3 in the ventral-dorsal direction. For monopolar
 stimulation, a single contact will be used for cathodic stimulation (1- or 2-) and a
 conductive pad will be placed on the subject's skin, outside of the sterile field, to serve
 as the return electrode. The recording contacts will be two other contacts on the DBS lead.
 For bipolar stimulation, DBS pulses will be applied between two electrode contacts, and the
 recording contacts will be the two remaining free contacts. The stimulus waveform will be a
 charge-balanced biphasic pulse, with charge restricted to values below the limit set by the
 manufacturer, 30 µC/cm2. Another conductive pad will be placed on the subject to serve as the
 recording reference. For subjects undergoing the DBS implantation surgery, the DBS lead
 cannula or a surgical retractor normally placed at the cranial incision site may also be used
 as the recording reference or return electrode.

 In subjects with tremor-dominant PD, the investigator will record both the tremor and DLEP
 and/or LFP responses from the DBS electrode. Several trials will be conducted with different
 stimulation amplitudes, frequencies (≤185 Hz), temporal patterns, and contact configurations.
 The stimulation amplitude will be less than that identified to be uncomfortable to the
 subject or that generates side effects, as determined by a neurologist and/or neurosurgeon
 during the initial testing phase following implantation. The different stimulation parameters
 will be delivered in randomized order, and the subject will be blinded to the parameters.
 Measurements will be made during 2-minute trials, in which stimulation will be off for the
 first minute of the trial, and on for the remaining minute. At 30 s into both the off
 (baseline) and on phases of the trial, tremor will be measured for 20 s. The neural activity
 will also be measured from the electrode during both the off and on phases. The total amount
 of time necessary for data collection will be about 45 minutes.

 Tremor will be measured using an accelerometer taped to the back of the subject's hand, and
 with the wrist extended such that the hand is parallel to the forearm. The elbow may either
 be supported or unsupported, depending on which induces greater tremor (determined prior to
 any trials in each subject). Tremor as measured by an accelerometer correlates well with
 clinical tremor rating scales [Elble et al, 2006].

 In subjects with Parkinson's disease who do not have dominant tremor symptoms, the
 investigator will record both bradykinesia testing responses and DLEP and/or LFP potentials.
 Several trials will be conducted with different stimulation amplitudes, mean frequencies
 (≤185 Hz), temporal patterns, and contact configurations. The maximum amplitude delivered
 will be determined as described as above. The different stimulation parameters will be
 delivered in randomized order, and the subject will be blinded to the parameters.
 Measurements will be made in 10-minute trials, in which stimulation will be off for the first
 five minutes of the trial, and on for the remaining five minutes. At approximately 90, 210
 and 250 s into both the off (baseline) and on phases of the trial, bradykinesia will be
 measured for 20 s. The neural activity will also be measured from the electrode during both
 the off and on phases of the trial. The total amount of time necessary for data collection
 will be about 45 minutes.

 For bradykinesia measurements, the subject will be instructed to press alternately the right
 and left buttons of a computer mouse with the index and middle finger of their hand as
 rapidly and regularly as possible. Bradykinesia will be measured as the timing of alternating
 finger presses, a validated test of bradykinesia [Taylor-Tavares et al., 2005].

 Before DBS surgery, the subject's baseline pathological motor symptoms may be assessed in the
 pre-operative setting, to familiarize the patient with the task ahead of the implant
 procedure. Tremor or bradykinesia will be measured using the previously-described
 accelerometer measurement or the mouse click task, respectively. This task will take about 5
 minutes, and will be performed in the DBS-off condition. No sedation will be administered
 until after this has been completed.

 Following DBS surgery, the subject's pre-operative MRI and post-operative high-resolution CT
 scans may be used to determine the location of DBS electrode contacts within the brain.
 Placement of the electrode during DBS implant surgery will not be altered by the research
 study.
Inclusion Criteria:

 -  Parkinson's disease (PD) patients who are scheduled to already undergo the planned
 deep brain electrode placement for treatment of their movement disorder at Duke
 University Medical Center.

 -  Able to understand the study and consent form, and interested in proceeding with
 research during the invasive brain surgery to receive a DBS system for treatment of
 PD.

 Exclusion Criteria:

 -  Inability to execute the motor tasks during the study.